AdministrationAgreement-v1.0(2017EN): verschil tussen versies
Naar navigatie springen
Naar zoeken springen
Geen bewerkingssamenvatting |
(Copy of) |
||
| (3 tussenliggende versies door dezelfde gebruiker niet weergegeven) | |||
| Regel 3: | Regel 3: | ||
Version: '''1.0''' <br> | Version: '''1.0''' <br> | ||
HCIM Status:Final<br> | HCIM Status:Final<br> | ||
Release: '''2017''' <br> | |||
Release status: Prepublished<br> | Release status: Prepublished<br> | ||
Release date: 04-09-2017 | |||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div> | ||
| Regel 74: | Regel 74: | ||
==Information Model== | ==Information Model== | ||
<BR> | <BR> | ||
<imagemap> Bestand:AdministrationAgreement-v1.0Model(EN).png | center | |||
rect 614 490 899 528 [[#AdministrationAgreementAdditionalInformationCodeList]] | |||
rect 678 385 899 455 [[#13342]] | |||
rect 172 190 286 260 [[#13355]] | |||
rect 172 285 301 355 [[#13345]] | |||
rect 336 491 555 531 [[#AdministrationAgreementStopTypeCodeList]] | |||
rect 355 99 484 169 [[InstructionsForUse-v1.0(2017EN)]] | |||
rect 528 99 657 169 [[MedicationAgreement-v1.0(2017EN)]] | |||
rect 701 99 899 169 [[Product-v1.0(2017EN)]] | |||
rect 769 289 899 359 [[#13344]] | |||
rect 172 95 301 165 [[HealthcareProvider-v3.1(2017EN)]] | |||
rect 419 385 579 455 [[#13341]] | |||
rect 172 380 301 450 [[TimeInterval-v1.0(2017EN)]] | |||
rect 740 194 899 264 [[#13349]] | |||
rect 480 248 590 318 [[#13347]] | |||
desc none | |||
</imagemap> | |||
<BR> | <BR> | ||
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | {| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | ||
| Regel 80: | Regel 96: | ||
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference | |style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference | ||
|-style="vertical-align:top; background-color: #E3E3E3; " | |-style="vertical-align:top; background-color: #E3E3E3; " | ||
|style = "text-align:center" |[[Bestand: block.png| 20px]] | |style = "text-align:center" |[[Bestand: block.png| 20px | link=]] | ||
||NL-CM:9.8.20132 | ||NL-CM:9.8.20132 | ||
|colspan ="6" style ="padding-left: 0px"|<span Title="NL: Toedieningsafspraak">[[Bestand: arrowdown.png | 10px]]AdministrationAgreement</span> | |colspan ="6" style ="padding-left: 0px"|<span Id=13347 Title="NL: Toedieningsafspraak">[[Bestand: arrowdown.png | 10px | link=]]AdministrationAgreement</span> | ||
| | | | ||
|Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model. | |Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model. | ||
| Regel 88: | Regel 104: | ||
| | | | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] | ||
||NL-CM:9.8.22097 | ||NL-CM:9.8.22097 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Verstrekker::Zorgaanbieder">[[Bestand: arrowright.png | 10px]]Supplier::HealthProfessional</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13343 Title="NL: Verstrekker::Zorgaanbieder">[[Bestand: arrowright.png | 10px | link=]]Supplier::HealthProfessional</span> | ||
|0..1 | |0..1 | ||
|The supplier (pharmacist) that entered the administration agreement. | |The supplier (pharmacist) that entered the administration agreement. | ||
| Regel 98: | Regel 114: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png]]||[[HealthcareProvider-v3.1(2017EN) |HealthcareProvider]] | |[[Bestand: block.png | link=HealthcareProvider-v3.1(2017EN)]]||[[HealthcareProvider-v3.1(2017EN) |HealthcareProvider]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] | ||
||NL-CM:9.8.20237 | ||NL-CM:9.8.20237 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GeneesmiddelBijToedieningsAfspraak::Product">[[Bestand: arrowright.png | 10px]]MedicineForAdministrationAgreement::Product</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13348 Title="NL: GeneesmiddelBijToedieningsAfspraak::Product">[[Bestand: arrowright.png | 10px | link=]]MedicineForAdministrationAgreement::Product</span> | ||
|1 | |1 | ||
|Medicine in the AdministrationAgreement. | |Medicine in the AdministrationAgreement. | ||
| Regel 111: | Regel 127: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png]]||[[Product-v1.0(2017EN) |Product]] | |[[Bestand: block.png | link=Product-v1.0(2017EN)]]||[[Product-v1.0(2017EN) |Product]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] | ||
||NL-CM:9.8.22098 | ||NL-CM:9.8.22098 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px]]InstructionsForUse</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13350 Title="NL: Gebruiksinstructie">[[Bestand: arrowright.png | 10px | link=]]InstructionsForUse</span> | ||
|0..1 | |0..1 | ||
|Instructions for administering the medication, e.g. dose and route of administration. | |Instructions for administering the medication, e.g. dose and route of administration. | ||
| Regel 124: | Regel 140: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]] | |[[Bestand: block.png | link=InstructionsForUse-v1.0(2017EN)]]||[[InstructionsForUse-v1.0(2017EN) |InstructionsForUse]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: TS.png| 16px]] | |style = "text-align:center" |[[Bestand: TS.png| 16px | link=]] | ||
||NL-CM:9.8.20133 | ||NL-CM:9.8.20133 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: ToedieningsafspraakDatumTijd">[[Bestand: arrowright.png | 10px]]AdministrationAgreementDateTime</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13349 Title="NL: ToedieningsafspraakDatumTijd">[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementDateTime</span> | ||
|0..1 | |0..1 | ||
|The time at which the agreement was made. | |The time at which the agreement was made. | ||
| Regel 136: | Regel 152: | ||
| | | | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: ST.png| 16px]] | |style = "text-align:center" |[[Bestand: ST.png| 16px | link=]] | ||
||NL-CM:9.8.22499 | ||NL-CM:9.8.22499 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: RedenAfspraak">[[Bestand: arrowright.png | 10px]]AgreementReason</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13344 Title="NL: RedenAfspraak">[[Bestand: arrowright.png | 10px | link=]]AgreementReason</span> | ||
|0..1 | |0..1 | ||
|Reason for this agreement. This will often be the same reason as the one for the medication agreement. | |Reason for this agreement. This will often be the same reason as the one for the medication agreement. | ||
| Regel 146: | Regel 162: | ||
| | | | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] | ||
||NL-CM:9.8.22660 | ||NL-CM:9.8.22660 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px]]PeriodOfUse</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13352 Title="NL: Gebruiksperiode::TijdsInterval">[[Bestand: arrowright.png | 10px | link=]]PeriodOfUse</span> | ||
|1 | |1 | ||
|Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued. | |Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued. | ||
| Regel 161: | Regel 177: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png]]||[[ | |[[Bestand: block.png | link=TimeInterval-v1.0(2017EN)]]||[[TimeInterval-v1.0(2017EN) |TimeInterval]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] | ||
||NL-CM:9.8.22394 | ||NL-CM:9.8.22394 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Medicatieafspraak">[[Bestand: arrowright.png | 10px]]MedicationAgreement</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13353 Title="NL: Medicatieafspraak">[[Bestand: arrowright.png | 10px | link=]]MedicationAgreement</span> | ||
|0..1 | |0..1 | ||
|Relationship to the medication agreement on which the administration agreement is based. | |Relationship to the medication agreement on which the administration agreement is based. | ||
| Regel 174: | Regel 190: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: block.png]]||[[MedicationAgreement-v1.0(2017EN) |MedicationAgreement]] | |[[Bestand: block.png | link=MedicationAgreement-v1.0(2017EN)]]||[[MedicationAgreement-v1.0(2017EN) |MedicationAgreement]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: CD.png| 16px]] | |style = "text-align:center" |[[Bestand: CD.png| 16px | link=]] | ||
||NL-CM:9.8.22498 | ||NL-CM:9.8.22498 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: ToediengingsafspraakStopType">[[Bestand: arrowright.png | 10px]]AdministrationAgreementStopType</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13341 Title="NL: ToediengingsafspraakStopType">[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementStopType</span> | ||
|0..1 | |0..1 | ||
|Stop type, the manner in which this medication is discontinued (temporary or definitive). | |Stop type, the manner in which this medication is discontinued (temporary or definitive). | ||
| Regel 187: | Regel 203: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: List2.png]]||[[#AdministrationAgreementStopTypeCodeList|AdministrationAgreementStopTypeCodeList]] | |[[Bestand: List2.png | link=#AdministrationAgreementStopTypeCodeList]]||[[#AdministrationAgreementStopTypeCodeList|AdministrationAgreementStopTypeCodeList]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: BL.png| 16px]] | |style = "text-align:center" |[[Bestand: BL.png| 16px | link=]] | ||
||NL-CM:9.8.23034 | ||NL-CM:9.8.23034 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GeannuleerdIndicator">[[Bestand: arrowright.png | 10px]]CanceledIndicator</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13355 Title="NL: GeannuleerdIndicator">[[Bestand: arrowright.png | 10px | link=]]CanceledIndicator</span> | ||
|0..1 | |0..1 | ||
|In the event of an error correction, this indicator is to be put on for the incorrect agreement. | |In the event of an error correction, this indicator is to be put on for the incorrect agreement. | ||
| Regel 199: | Regel 215: | ||
| | | | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: CD.png| 16px]] | |style = "text-align:center" |[[Bestand: CD.png| 16px | link=]] | ||
||NL-CM:9.8.23284 | ||NL-CM:9.8.23284 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: ToedieningsafspraakAanvullendeInformatie">[[Bestand: arrowright.png | 10px]]AdministrationAgreementAdditionalInformation</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13342 Title="NL: ToedieningsafspraakAanvullendeInformatie">[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementAdditionalInformation</span> | ||
|0..* | |0..* | ||
|Additional information includes details on the structure of the agreement made. | |Additional information includes details on the structure of the agreement made. | ||
| Regel 212: | Regel 228: | ||
{| | {| | ||
|- | |- | ||
|[[Bestand: List2.png]]||[[#AdministrationAgreementAdditionalInformationCodeList|AdministrationAgreementAdditionalInformationCodeList]] | |[[Bestand: List2.png | link=#AdministrationAgreementAdditionalInformationCodeList]]||[[#AdministrationAgreementAdditionalInformationCodeList|AdministrationAgreementAdditionalInformationCodeList]] | ||
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
|style = "text-align:center" |[[Bestand: ST.png| 16px]] | |style = "text-align:center" |[[Bestand: ST.png| 16px | link=]] | ||
||NL-CM:9.8.22275 | ||NL-CM:9.8.22275 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Comment</span> | |colspan ="5" style ="padding-left: 0px"|<span Id=13345 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span> | ||
|0..1 | |0..1 | ||
|Comments on the administration agreement. | |Comments on the administration agreement. | ||
| Regel 236: | Regel 252: | ||
{|class="wikitable" width="1225px" style= "font-size: 9.5pt;" | {|class="wikitable" width="1225px" style= "font-size: 9.5pt;" | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #1F497D; width: 12%; color | | style="background-color: #1F497D; width: 12%; "|<font color=#FFFFFF><b>ToedieningsAfspraakDatumTijd</b></font> | ||
| style="background-color: #1F497D; width: 12%; color | | style="background-color: #1F497D; width: 12%; "|<font color=#FFFFFF><b>Gebruiksperiode</b></font> | ||
| style="background-color: #1F497D; width: 8%; "| | | style="background-color: #1F497D; width: 8%; "| | ||
| style="background-color: #1F497D; width: 7%; "| | | style="background-color: #1F497D; width: 7%; "| | ||
| style="background-color: #1F497D; width: 18%; color | | style="background-color: #1F497D; width: 18%; "|<font color=#FFFFFF><b>GeneesmiddelBijToedieningsafspraak</b></font> | ||
| style="background-color: #1F497D; width: 19%; color | | style="background-color: #1F497D; width: 19%; "|<font color=#FFFFFF><b>Verstrekker</b></font> | ||
| style="background-color: #1F497D; width: 9%; color | | style="background-color: #1F497D; width: 9%; "|<font color=#FFFFFF><b>GeannuleerdIndicator</b></font> | ||
| style="background-color: #1F497D; width: 15%; color | | style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>ToedieningsafspraakStoptype</b></font> | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #548DD4; width: 12%; "| | | style="background-color: #548DD4; width: 12%; "| | ||
| style="background-color: #548DD4; width: 12%; color | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>Ingangsdatum</b></font> | ||
| style="background-color: #548DD4; width: 8%; color | | style="background-color: #548DD4; width: 8%; "|<font color=#FFFFFF><b>Einddatum</b></font> | ||
| style="background-color: #548DD4; width: 7%; color | | style="background-color: #548DD4; width: 7%; "|<font color=#FFFFFF><b>Duur</b></font> | ||
| style="background-color: #548DD4; width: 18%; color | | style="background-color: #548DD4; width: 18%; "|<font color=#FFFFFF><b>ProductCode</b></font> | ||
| style="background-color: #548DD4; width: 19%; color | | style="background-color: #548DD4; width: 19%; "|<font color=#FFFFFF><b>Zorgaanbieder</b></font> | ||
| style="background-color: #548DD4; width: 9%; "| | | style="background-color: #548DD4; width: 9%; "| | ||
| style="background-color: #548DD4; width: 15%; "| | | style="background-color: #548DD4; width: 15%; "| | ||
| Regel 263: | Regel 279: | ||
| style="background-color: #D9D9D9; width: 15%; "| | | style="background-color: #D9D9D9; width: 15%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 12% | | style="width: 12%; "|2-5-2012 12:14:09 | ||
| style="width: 12% | | style="width: 12%; "|02-05-12 | ||
| style="width: 8%; "| | | style="width: 8%; "| | ||
| style="width: 7% | | style="width: 7%; "|4 weken | ||
| style="width: 18% | | style="width: 18%; "|Paracetamol tablet 500 mg | ||
| style="width: 19% | | style="width: 19%; "|Apotheek De Gulle Gaper | ||
| style="width: 9%; "| | | style="width: 9%; "| | ||
| style="width: 15%; "| | | style="width: 15%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 12% | | style="width: 12%; "|10-9-2015 9:16:31 | ||
| style="width: 12%; "| | | style="width: 12%; "| | ||
| style="width: 8%; "| | | style="width: 8%; "| | ||
| style="width: 7% | | style="width: 7%; "|5 dagen | ||
| style="width: 18% | | style="width: 18%; "|Pantoprazol injpdr 40 mg fl | ||
| style="width: 19% | | style="width: 19%; "|Apotheek De Gulle Gaper | ||
| style="width: 9% | | style="width: 9%; "|Ja | ||
| style="width: 15%; "| | | style="width: 15%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 12% | | style="width: 12%; "|19-9-2014 7:12:59 | ||
| style="width: 12% | | style="width: 12%; "|19-09-14 | ||
| style="width: 8% | | style="width: 8%; "|18-12-14 | ||
| style="width: 7%; "| | | style="width: 7%; "| | ||
| style="width: 18% | | style="width: 18%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | ||
| style="width: 19% | | style="width: 19%; "|Poli-apotheek Het Ziekenhuis | ||
| style="width: 9%; "| | | style="width: 9%; "| | ||
| style="width: 15%; "| | | style="width: 15%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 12% | | style="width: 12%; "|30-8-2013 8:41:43 | ||
| style="width: 12% | | style="width: 12%; "|01-08-13 | ||
| style="width: 8% | | style="width: 8%; "|30-08-13 | ||
| style="width: 7%; "| | | style="width: 7%; "| | ||
| style="width: 18% | | style="width: 18%; "|Prednison 5 mg | ||
| style="width: 19% | | style="width: 19%; "|Poli-apotheek Het Ziekenhuis | ||
| style="width: 9%; "| | | style="width: 9%; "| | ||
| style="width: 15% | | style="width: 15%; "|Definitief | ||
|} | |} | ||
{|class="wikitable" width="1225px" style= "font-size: 9.5pt;" | {|class="wikitable" width="1225px" style= "font-size: 9.5pt;" | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #1F497D; width: 22%; color | | style="background-color: #1F497D; width: 22%; "|<font color=#FFFFFF><b>Gebruiksinstructie</b></font> | ||
| style="background-color: #1F497D; width: 9%; "| | | style="background-color: #1F497D; width: 9%; "| | ||
| style="background-color: #1F497D; width: 11%; "| | | style="background-color: #1F497D; width: 11%; "| | ||
| Regel 309: | Regel 325: | ||
| style="background-color: #1F497D; width: 8%; "| | | style="background-color: #1F497D; width: 8%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #548DD4; width: 22%; color | | style="background-color: #548DD4; width: 22%; "|<font color=#FFFFFF><b>Omschrijving</b></font> | ||
| style="background-color: #548DD4; width: 9%; color | | style="background-color: #548DD4; width: 9%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font> | ||
| style="background-color: #548DD4; width: 11%; color | | style="background-color: #548DD4; width: 11%; "|<font color=#FFFFFF><b>HerhaalperiodeCyclischSchema</b></font> | ||
| style="background-color: #548DD4; width: 13%; color | | style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Doseerinstructie</b></font> | ||
| style="background-color: #548DD4; width: 13%; "| | | style="background-color: #548DD4; width: 13%; "| | ||
| style="background-color: #548DD4; width: 23%; "| | | style="background-color: #548DD4; width: 23%; "| | ||
| Regel 320: | Regel 336: | ||
| style="background-color: #D9D9D9; width: 9%; "| | | style="background-color: #D9D9D9; width: 9%; "| | ||
| style="background-color: #D9D9D9; width: 11%; "| | | style="background-color: #D9D9D9; width: 11%; "| | ||
| style="background-color: #D9D9D9; width: 13% | | style="background-color: #D9D9D9; width: 13%; "|<b>Doseerduur</b> | ||
| style="background-color: #D9D9D9; width: 13% | | style="background-color: #D9D9D9; width: 13%; "|<b>Dosering<noWiki>|</noWiki>Keerdosis</b> | ||
| style="background-color: #D9D9D9; width: 23% | | style="background-color: #D9D9D9; width: 23%; "|<b>Toedieningsschema<noWiki>|</noWiki>Frequentie<noWiki>|</noWiki>Interval<noWiki>|</noWiki>Toedientijd<noWiki>|</noWiki>Weekdag<noWiki>|</noWiki>Dagdeel</b> | ||
| style="background-color: #D9D9D9; width: 8% | | style="background-color: #D9D9D9; width: 8%; "|<b>Zo nodig</b> | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 22% | | style="width: 22%; "|Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag | ||
| style="width: 9% | | style="width: 9%; "|oraal | ||
| style="width: 11% | | style="width: 11%; "|1 | ||
| style="width: 13% | | style="width: 13%; "|4 weken | ||
| style="width: 13% | | style="width: 13%; "|1 stuk | ||
| style="width: 23% | | style="width: 23%; "|max. 4x/dag | ||
| style="width: 8% | | style="width: 8%; "|Bij pijn | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 22% | | style="width: 22%; "|Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st) | ||
| style="width: 9% | | style="width: 9%; "|iv | ||
| style="width: 11%; "| | | style="width: 11%; "| | ||
| style="width: 13%; "| | | style="width: 13%; "| | ||
| style="width: 13% | | style="width: 13%; "|40 mg (=1 st) | ||
| style="width: 23% | | style="width: 23%; "|1x per dag om 8.00 uur | ||
| style="width: 8%; "| | | style="width: 8%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 22% | | style="width: 22%; "|Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml) | ||
| style="width: 9% | | style="width: 9%; "|subcutaan | ||
| style="width: 11%; "| | | style="width: 11%; "| | ||
| style="width: 13%; "| | | style="width: 13%; "| | ||
| style="width: 13% | | style="width: 13%; "|2500 IE (=0,2 ml) | ||
| style="width: 23% | | style="width: 23%; "|1x per dag om 18.00 uur | ||
| style="width: 8%; "| | | style="width: 8%; "| | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 22% | | style="width: 22%; "|Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken. | ||
| style="width: 9% | | style="width: 9%; "|oraal | ||
| style="width: 11% | | style="width: 11%; "|1 | ||
| style="width: 13%; "| | | style="width: 13%; "| | ||
| style="width: 13%; "| | | style="width: 13%; "| | ||
| Regel 500: | Regel 516: | ||
==This information model in other releases== | |||
--- | |||
==More on this information model== | ==More on this information model== | ||
To exchange information based on health and care information models, additional, more technical specifications are required.<BR> | |||
This information model is also available as [[Media:nl.zorg.AdministrationAgreement-v1.0( | Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications: | ||
<ul> | |||
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.8&effectiveDate=2017-09-04T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li> | |||
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=Profile [[File:fhir.png|link=]]]</li> | |||
</ul> | |||
This information model is also available as [[Media:nl.zorg.AdministrationAgreement-v1.0(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.AdministrationAgreement-v1.0(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]] | |||
==About this information== | ==About this information== | ||
The information in this wikipage is based on Prerelease 2017 #1 <BR> | The information in this wikipage is based on Prerelease 2017 #1 <BR> | ||
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR> | Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR> | ||
This page is generated on | This page is generated on 30/11/2017 13:38:19 <BR> | ||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div> | ||
Huidige versie van 20 feb 2018 om 10:04
General information
Name: nl.zorg.AdministrationAgreement 
Version: 1.0
HCIM Status:Final
Release: 2017
Release status: Prepublished
Release date: 04-09-2017
Metadata
| DCM::CoderList | Projectgroep Medicatieproces |
| DCM::ContactInformation.Address | |
| DCM::ContactInformation.Name | * |
| DCM::ContactInformation.Telecom | |
| DCM::ContentAuthorList | Projectgroep Medicatieproces |
| DCM::CreationDate | 1-2-2017 |
| DCM::DeprecatedDate | |
| DCM::DescriptionLanguage | nl |
| DCM::EndorsingAuthority.Address | |
| DCM::EndorsingAuthority.Name | PM |
| DCM::EndorsingAuthority.Telecom | |
| DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.9.8 |
| DCM::KeywordList | Medicatie, Toediening |
| DCM::LifecycleStatus | Final |
| DCM::ModelerList | Architectuurgroep Registratie aan de Bron |
| DCM::Name | nl.zorg.Toedieningsafspraak |
| DCM::PublicationDate | 04-09-2017 |
| DCM::PublicationStatus | Prepublished |
| DCM::ReviewerList | Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron |
| DCM::RevisionDate | 04-09-2017 |
| DCM::Superseeds | nl.zorg.MedicatieVerstrekking-v3.0 |
| DCM::Version | 1.0 |
| HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (04-09-2017).
Concept
An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.
Purpose
The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.
Information Model
| Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | |||||||
|
NL-CM:9.8.20132 |  AdministrationAgreement
|
Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model. | ||||||||||
|
NL-CM:9.8.22097 |  Supplier::HealthProfessional
|
0..1 | The supplier (pharmacist) that entered the administration agreement. |
| ||||||||
|
|
NL-CM:9.8.20237 | MedicineForAdministrationAgreement::Product
|
1 | Medicine in the AdministrationAgreement. |
| ||||||||
|
|
NL-CM:9.8.22098 | InstructionsForUse
|
0..1 | Instructions for administering the medication, e.g. dose and route of administration. |
| ||||||||
|
NL-CM:9.8.20133 | AdministrationAgreementDateTime
|
0..1 | The time at which the agreement was made. | |||||||||
|
NL-CM:9.8.22499 | AgreementReason
|
0..1 | Reason for this agreement. This will often be the same reason as the one for the medication agreement.
This field has the option to - if applicable - enter a specific reason for the administration agreement. Examples include: substitution, transfer to GDS, patient request for different product, etc. |
|||||||||
|
|
NL-CM:9.8.22660 | PeriodOfUse
|
1 | Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original medication agreement. The end date indicates from when the medication is to be discontinued.
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days. End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date. |
| ||||||||
|
|
NL-CM:9.8.22394 | MedicationAgreement
|
0..1 | Relationship to the medication agreement on which the administration agreement is based. |
| ||||||||
|
NL-CM:9.8.22498 | AdministrationAgreementStopType
|
0..1 | Stop type, the manner in which this medication is discontinued (temporary or definitive). |
| ||||||||
|
NL-CM:9.8.23034 | CanceledIndicator
|
0..1 | In the event of an error correction, this indicator is to be put on for the incorrect agreement. | |||||||||
|
|
NL-CM:9.8.23284 | AdministrationAgreementAdditionalInformation
|
0..* | Additional information includes details on the structure of the agreement made.
This element mainly contains information that until now has been structured with ZZ rules. The medication-related topics that are now supported by the ZZ rules are best supported with a system functionality. A process has been started for this by Z-index/KNMP. For now, the following list will be used. This list will be replaced by a thesaurus in the G standard at a later stage. |
| ||||||||
|
|
NL-CM:9.8.22275 | Comment
|
0..1 | Comments on the administration agreement. |
|
||||||||
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page 
Example Instances
Only available in Dutch
| ToedieningsAfspraakDatumTijd | Gebruiksperiode | GeneesmiddelBijToedieningsafspraak | Verstrekker | GeannuleerdIndicator | ToedieningsafspraakStoptype | ||
| Ingangsdatum | Einddatum | Duur | ProductCode | Zorgaanbieder | |||
| 2-5-2012 12:14:09 | 02-05-12 | 4 weken | Paracetamol tablet 500 mg | Apotheek De Gulle Gaper | |||
| 10-9-2015 9:16:31 | 5 dagen | Pantoprazol injpdr 40 mg fl | Apotheek De Gulle Gaper | Ja | |||
| 19-9-2014 7:12:59 | 19-09-14 | 18-12-14 | Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | Poli-apotheek Het Ziekenhuis | |||
| 30-8-2013 8:41:43 | 01-08-13 | 30-08-13 | Prednison 5 mg | Poli-apotheek Het Ziekenhuis | Definitief |
| Gebruiksinstructie | ||||||
| Omschrijving | ToedieningsWeg | HerhaalperiodeCyclischSchema | Doseerinstructie | |||
| Doseerduur | Dosering|Keerdosis | Toedieningsschema|Frequentie|Interval|Toedientijd|Weekdag|Dagdeel | Zo nodig | |||
| Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag | oraal | 1 | 4 weken | 1 stuk | max. 4x/dag | Bij pijn |
| Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st) | iv | 40 mg (=1 st) | 1x per dag om 8.00 uur | |||
| Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml) | subcutaan | 2500 IE (=0,2 ml) | 1x per dag om 18.00 uur | |||
| Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken. | oraal | 1 |
Valuesets
AdministrationAgreementAdditionalInformationCodeList
| Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.2 |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Geneesmiddel niet verstrekt | 1 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Niet leverbaar | 2 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Medicatieafspraak gewijzigd: substantie | 3 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Medicatieafspraak gewijzigd: dosering | 4 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Medicatieafspraak gewijzigd: farmaceutische vorm | 5 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Medicatieafspraak gewijzigd: verwisseling van persoon | 6 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Machtiging aangevraagd | 7 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Machtiging afgewezen | 8 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Machtiging in gebruik nemen | 9 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Gebruiksinstructie gegeven | 10 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Controle inhalatietechniek | 11 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Meter periodieke controle | 12 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Pen controle/omruil | 13 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Bijwerking besproken | 14 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Afhandeling bijwerking niet-lareb | 15 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Melding lareb | 16 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 | |
| Medicatiebewaking OT | 17 | Voorlopige aanvullende informatie toedieningsafspraak | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999 |
AdministrationAgreementStopTypeCodeList
| Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1 |
| Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
| Tijdelijk | 1 | StopType | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 | Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie). |
| Definitief | 2 | StopType | 2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1 | Het staken van een bestaande medicamenteuze behandeling. |
This information model in other releases
---
More on this information model
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
This information model is also available as pdf file 
or as spreadsheet 
About this information
The information in this wikipage is based on Prerelease 2017 #1
Conditions for use are located on the mainpage
This page is generated on 30/11/2017 13:38:19